Equities research analysts at William Blair decreased their FY2026 earnings per share estimates for shares of Bristol-Myers ...
BeiGene, a global biotech firm that develops cancer medicines, has opened a 400,000-square-foot life sciences facility in ...
Drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a share-price ...
The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...
R Squared Ltd purchased a new position in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the 4th quarter, according to its ...
We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take ...
In an amicus brief, several advocacy groups warned that letting the lawsuit proceed past a motion to dismiss could open the ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...
Bristol-Myers Squibb’s $2.6B pension risk transfer lawsuit is ‘frivolous,’ say industry groups
The ERISA Industry Committee, along with two other industry groups, is seeking the dismissal of the drugmaker’s PRT lawsuit ...
Simon Squibb, who has amassed more than 12 million followers across TikTok, YouTube and Instagram, will appear at the Citizen Hub in St Neots on January 31. Originally from St Neots, Squibb is best ...
To get a sense of who is truly in control of Bristol-Myers Squibb Company (NYSE:BMY), it is important to understand the ownership structure of the business. And the group that holds the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback